Next Article in Journal
Progress in Lewis-Acid-Templated Diels–Alder Reactions
Next Article in Special Issue
Structural Characterization and Bioactivity of a Titanium(IV)-Oxo Complex Stabilized by Mandelate Ligands
Previous Article in Journal
Current Trends in Sirtuin Activator and Inhibitor Development
Previous Article in Special Issue
Reaction of Partially Methylated Polygalacturonic Acid with Iron(III) Chloride and Characterization of a New Mixed Chloride–Polygalacturonate Complex
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 29
Issue 5
10.3390/molecules29051186
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis, Crystal Structures, Genotoxicity, and Antifungal and Antibacterial Studies of Ni(II) and Cd(II) Pyrazole Amide Coordination Complexes

by
Amal El Mahdaoui
1,
Smaail Radi
1,*,
Youssef Draoui
1,
Mohamed El Massaoudi
1,
Sabir Ouahhoud
2,3,
Abdeslam Asehraou
2,
Nour Eddine Bentouhami
2,
Ennouamane Saalaoui
2,
Redouane Benabbes
2,
Koen Robeyns
4 and
Yann Garcia
4,*
1
LCAE, Department of Chemistry, Faculty of Sciences, University Mohammed I, Oujda 60000, Morocco
2
Laboratory of Bioresource Biotechnology Ethnopharmacology and Health, Faculty of Sciences, University Mohammed I, Oujda 60000, Morocco
3
Faculty of Medicine and Pharmacy, University Sultan Moulay Slimane, Beni Mellal 23000, Morocco
4
Institute of Condensed Matter and Nanosciences, Molecular Chemistry, Materials and Catalysis (IMCN/MOST), Université Catholique de Louvain, Place Louis Pasteur 1, 1348 Louvain-la-Neuve, Belgium
*
Authors to whom correspondence should be addressed.
Molecules 2024, 29(5), 1186; https://doi.org/10.3390/molecules29051186
Submission received: 2 February 2024 / Revised: 25 February 2024 / Accepted: 5 March 2024 / Published: 6 March 2024
(This article belongs to the Special Issue Synthesis, Structure, Molecular Modeling, and Bioactivity of Metal Complexes)
Browse Figures
Versions Notes

Abstract

:
In this study, we synthesized two coordination complexes based on pyrazole-based ligands, namely 1,5-dimethyl-N-phenyl-1H-pyrazole-3-carboxamide (L1) and 1,5-dimethyl-N-propyl-1H-pyrazole-3-carboxamide (L2), with the aim to investigate bio-inorganic properties. Their crystal structures revealed a mononuclear complex [Ni(L1)2](ClO4)2 (C1) and a dinuclear complex [Cd2(L2)2]Cl4 (C2). Very competitive antifungal and anti-Fusarium activities were found compared to the reference standard cycloheximide. Additionally, L1 and L2 present very weak genotoxicity in contrast to the observed increase in genotoxicity for the coordination complexes C1 and C2.

1. Introduction

The growing problem of antibiotic resistance poses a significant threat to global health and food security. Bacteria are becoming increasingly resistant to commonly used antibiotics, forcing the use of less effective alternatives for treating common infections. This has led to the emergence of multi-drug-resistant pathogens, which the World Health Organization has identified as a major global health concern. Therefore, there is an immediate need to discover new types of medicines that can effectively fight these resistant strains [1,2].
In the field of pharmaceuticals, most compounds, including lead structures, are typically organic in nature. This preference for organic compounds may seem obvious, given that metals and their compounds are primarily associated with industrial and catalytic applications and often linked to toxicity concerns. It is however interesting to note that metal-based coordination complexes have played vital roles in the history of medicine. Examples include arsenic’s use in the first effective syphilis treatment (Salvarsan), mercury in the antiseptic mercurochrome and vaccine preservative thiomersal, or gold in treating rheumatoid arthritis (Auranofin) [3].
We recently turned our interest to pyrazole molecules due to their versatility and ability to engage in extensive interactions, making them particularly advantageous in the design and synthesis of metal–organic coordination compounds [4,5,6,7,8,9,10,11,12,13]. Such complexes could be proposed for various applications such as metal ion extraction [14,15,16], catalysis [17], adsorbents of heavy metals [18,19,20,21,22], and corrosion inhibitors [23,24]. Additionally, pyrazole compounds have attracted considerable interest due to their broad spectrum of biological properties. These versatile compounds have shown significant potential as antibacterial, antifungal, anticancer, antioxidant, anti-inflammatory, antidepressant, antipyretic, antiviral, anti-tubercular, and anti-HIV agents [6,10,11,12,24,25,26,27,28]. The diverse range of biological effects exhibited by pyrazole molecules has made them a subject of extensive research in medicinal and pharmaceutical studies [29,30].
Metal complexes incorporating an amide functional group have gained considerable attention too. Amides possess broad biological properties and are utilized as effective chelating agents. Notably, amide groups incorporated into heterocyclic bases such as pyridine and pyrazine have emerged as a rapidly expanding class of ligand scaffolds that efficiently bind metal ions [31].
This study primarily focuses on the synthesis and characterization of two coordination complexes based on pyrazole amide ligands as antibiotic agents, namely 1,5-dimethyl-N-phenyl-1H-pyrazole-3-carboxamide (L1, Scheme 1) and 1,5-dimethyl-N-propyl-1H-pyrazole-3-carboxamide (L2). To do so, we examined the reactivity of L1 in methanol with [Ni(H2O)6](ClO4)2 which led to a mononuclear complex [Ni(L1)2](ClO4)2 (C1). Additionally, we explored the reactivity in methanol of L2 with CdCl2·2.5H2O, which led to a dinuclear complex [Cd2(L2)2]Cl4 (C2).
To assess the applicability of these compounds in real-world settings, their antibacterial and antifungal properties were studied. All compounds demonstrated antimicrobial activity against Gram (+) bacteria Listeria innocua and Staphylococcus aureus, as well as Gram (−) bacteria such as Escherichia coli and Pseudomonas aeruginosa and antifungal activity against pathogenic fungi Geotrichum candidum, Aspergillus niger, and Penicillium crustosum. Studying the genotoxicity of our compounds is also key to assessing their safety and evaluating their harmful effects for use cases in medicine, agriculture, and other applications. Minimal genotoxicity was observed for L1 and L2, but a significant rise in genotoxicity was exhibited for C1 and C2.

2. Results and Discussion

2.1. Synthesis of the Ligands

Since pyrazole has desirable biological properties, as outlined in the introduction, we used ethyl 1,5-dimethyl-1H-pyrazole-3-carboxylate as a starting point. Next, we performed the hydrolysis of the previous compound using methanol and NaOH to obtain 1,5-dimethyl-1H-pyrazole-3-carboxylic acid (A1). In the following step, A1 was dissolved in dichloromethane along with thionyl chloride SOCl2 under stirring to obtain 1,5-dimethyl-1H-pyrazol-3-carbonyl chloride (A2). The goal of the previous hydrolysis and chlorination steps was to be able to add the amide function to our compound, which is known to have desirable biological properties as mentioned in the introduction. In addition, A2 (Scheme 1) was combined with a mixture of triethylamine and aniline in CH2Cl2. The mixture was heated at reflux for 24 h, filtered, and concentrated. The final product (L1) was obtained as a white powder with a high yield (93%). Afterwards, A2 was combined with a mixture of propylamine and triethylamine in toluene. The resulting mixture was refluxed for 24 h, filtered, and the solvent was removed. The crude product was purified via column chromatography on silica gel, affording L2 as a white solid with a high yield (84%) (Scheme 1).

2.2. Synthesis of the Complexes

We aimed to investigate the influence of metal and counter anion selection on the formation and structural features of our coordination complexes, assessing their biological applications. To accomplish this, we utilized different ligand/metal ratios, experimented with diverse metal salts featuring varying counter anions, and employed various crystallization methods and solvents. From the compounds studied, C1 and C2 stood out as the most promising, producing high-quality single crystals suitable for X-ray analysis. The synthesis of the coordination complexes was conducted following Scheme 2. Here, a methanolic solution of Ni(ClO4)2·6H2O was added to a methanolic solution of L1. After four days of slow evaporation, blue single crystals of C1 were obtained. A similar synthesis was carried out with L2 and CdCl2·H2O. Vapor diffusion with diethyl ether led to colorless single crystals of C2.

2.3. FT-IR Spectroscopy

Figure 1 reveals FT-IR spectra of L1, L2, and their respective coordination complexes C1 and C2. The purpose of this analysis was to observe the distinctive bands of the ligands and track their shifts upon coordination with the transition metals. Characteristic bands (2949(1) cm−1) of the aromatic C-H are observed in both L1 and L2. Additionally, bands at 3279 cm−1 and 3276 cm−1 for L1 and L2, respectively, reveal N-H vibrations of the amine groups. Additionally, amide C=O bands are observed at 1658 cm−1 and 1685 cm−1 for L1 and L2, respectively. Furthermore, ~1537 cm−1 corresponds to C=C aromatic stretching in both L1 and L2. C-O vibrations of the alkyl group function in L2 are detected at 1037 cm−1 and 1241 cm−1.
By comparing L1, C1 and L2, C2, respectively, a shift in the bands is systematically observed, which points to metal coordination. Furthermore, the peak at 1058 cm−1 becomes stronger in C1 compared to L1, which can be explained by the presence of non-coordinating perchlorate anions [32]. Using FT-IR, we were unable to observe bands corresponding to Cd-O, Cd-N, Ni-O, and Ni-N, which are theoretically expected below 500 cm−1 [33,34,35]. However, we were able to confirm the formation of the respective complexes by X-ray crystallography.

2.4. X-ray Crystallography

L1 crystallizes in the orthorhombic system, in space group Pbca (#61). The asymmetric unit contains one ligand L1 (Z = 8). A single hydrogen bond between the N-H and C=O propagates along the b-axis (Figure 2a). Complex C1 crystallizes in the monoclinic system, in space group P21/n (#14). The crystal structure shows a nickel mononuclear complex, the metal ion being coordinated by two bidentate chelating L1 ligands in the equatorial position and two methanol molecules in axial positions (Figure 2b). The complex is perfectly symmetrical, with the Ni atom found at a crystallographic inversion center; the asymmetric unit consists thus of half a C1 nickel complex with a single perchlorate as a counter anion (Z′ = 0.5).
Complex C2 crystallizes in the orthorhombic system, in space group Pca21 (#29). The asymmetric unit consists of two dinuclear complexes, one being solvated with two methanol molecules, giving an octahedral geometry around the Cd atoms, the other without any coordinated solvent molecules, giving a square pyramidal geometry for the Cd atoms. In either case, the Cd centers are complexed with a bidentate chelating L2 ligand, one chloride anion, and two bridging chloride anions with a 3.74 Å Cd···Cd separation distance for the desolvated complex and a 3.60 Å Cd···Cd separation dinuclear for the solvated dinuclear complex.

2.5. Antibacterial Activity

Screening of the antibacterial activities of L1, L2, C1, and C2 against Gram (+) (Listeria innocua and Staphylococcus aureus) and Gram (−) (Escherichia coli and Pseudomonas aeruginosa) bacteria was undertaken. Interestingly, there is an increase in the inhibition of C1 and C2 compared to L1 and L2, respectively, despite the lower concentration of the coordination complexes (see Figure 3 and Table 1). This enhanced performance can be attributed primarily to the influence of transition metals, which increase the lipophilicity of the coordination complexes compared to organic molecules [36]. As a result, the lipid membrane bilayer becomes more permeable to these complexes, facilitating their transfer [36]. This effect is more pronounced for C2 compared to L2. C2 provides the highest inhibition compared to L1, L2 and C1 on all bacteria tested. C2 displays a 16.1 mm inhibition zone on E. coli, which is half of the inhibition zone provided by the control, Gentamicin. It is therefore higher than the dinuclear complex [Cd2(dmamp)2(NCS)2]n (where dmamp = 2-[(2-dimethylaminoethylimino)methyl]phenol) [37] and of the same range as another dinuclear complex, CdL2Cl2, where L = 2-(3,5,5′-trimethyl-1′H-[1,3′-bipyrazol]-1′-yl)acetonitrile [38] (see Table 1). This result could be attributed to the superior antibacterial activity of pyrazole. Finally, note that Cd and Ni salts used in the synthesis of our coordination complexes display a weak antibacterial activity [38] that does not significantly affect the activity of our coordination complexes (see Table 1).

2.6. Antifungal Activity

We now focus our attention on the antifungal activity of our ligands and complexes against Geotrichum candidum, Aspergillus niger, and Penicillium crustosum. Coordination complexes C1 and C2 exhibit a noticeable increase in the inhibition zone compared to both L1 and L2 (Table 2), similar to the observed behavior in the previous section for the antibacterial activity. Additionally, the antifungal activity of C1 and C2 is generally comparable to that of cycloheximide. In particular, the inhibition zone of C2 against A. niger (24.5 ± 0.71 mm) and P. crustosum (26 ± 2.83 mm) is slightly higher, with statistical significance (p < 0.05), compared to the reference cycloheximide [40]. This result confirms that C2 has a very strong antifungal attitude. Additionally, C2 also has comparable antifungal activity compared to a Ni coordination complex [41] and a superior activity compared to other Cd and Ni coordination complexes [38,42,43,44] (see Table 2). Similar to the antibacterial activities, note that Cd and Ni salts only show a weak antifungal activity [38] (see Table 2).

2.7. Antifungal Activity on Mycelial Growth of Fusarium oxysporum f. sp. Albinidis

Our ligands and coordination complexes display anti-Fusarium properties in contrast to cycloheximide (see Table 3), but our coordination complexes show stronger anti-Fusarium properties compared to the ligands even though our complexes were used in lower concentrations. In particular, C2 exhibits a remarkable inhibition of 96% even at low concentrations (78.9 µmol/L) compared to all other compounds, including cycloheximide. Its characteristics overcome reported values for ligand molecules [46,47] in addition to other Cd and Ni coordination complexes (Table 3). The anti-Fusarium inhibition activity of our C2 is also comparable to the remarkable inhibition properties of two dinuclear Co and Cu complexes reported recently [38,44]. Remarkably, the Cd and Ni salts used for the synthesis of our coordination complexes have a weak anti-Fusarium activity [38] (Table 3).

2.8. Genotoxicity

To assess the genotoxicity of L1 and L2 as well as of the coordination complexes C1 and C2, we report the tail intensity, tail length, and tail moment (see Figure 3). For the sake of comparison, we compare their genotoxicity with hydrogen peroxide, which is known for being a typical DNA-damage-inducing agent [47]. L1 and L2 have weak genotoxicity compared to the negative control, whereas an increase in genotoxicity is found for C1 and C2 in comparison to hydrogen peroxide. This effect is likely due to the fact that Ni and Cd have a relatively high genotoxic activity [48,49]. Note that Cd is a toxic metal that accumulates in tissues and can cause genotoxic effects, including DNA damage and chromosomal aberrations, and disrupt DNA repair mechanisms. Additionally, Cd inhibits DNA methylation, altering gene expression patterns. Chronic exposure to cadmium is associated with an increased cancer risk [50]. Nickel, widely used in industries like stainless steel production, is classified as a human carcinogen. It induces genotoxic effects through DNA damage, chromosomal aberrations, and interference with DNA repair mechanisms, particularly in occupations such as mining and welding [51].

3. Experimental Section

3.1. Materials and Instrumentation

Commercially available analytical-grade solvents and chemicals were used without any additional purification steps. 1H and 13C NMR spectra were acquired using a Bruker AC 300 spectrometer (Bruker, Billerica, MA, USA). ESI ionization was employed to acquire HRMS data using a Q Exactive ion trap spectrometer from Thermo Fisher Scientific (Waltham, MA, USA), enabling high-resolution mass spectrometry measurements for C1 and C2. For the compounds L1 and L2, we used a low-resolution (LXQ) ESI MS. FT-IR spectra were recorded on a JASCO FT/IR-4700 spectrometer (JASCO, Lexington, KY, USA) using an ATR attachment. Melting points were measured using a Koffler bench. Elemental analyses were performed using a EuroEA Elemental Analyzer (HEKAtech GmbH, Wegberg, Germany).

3.2. Synthesis Section

3.2.1. Synthesis of Ethyl 1,5-Dimethyl-1H-pyrazole-3-carboxylate

Ethyl 5-methyl-1H-pyrazole-3-carboxylate 10 g (65 mmol) and tBuOK 7.9g (65 mmol) were introduced into anhydrous diethyl ether (230 mL). The reaction mixture was then heated under reflux for 1 h, and subsequently cooled using ice. Next, a solution of methyl iodide was added dropwise, and the mixture was refluxed for 4 h, then filtered and concentrated to dryness. To the resulting oil, 25 mL of hexane was added, and the solution was placed in a refrigerator overnight. The product obtained after filtration was in the form of yellowish crystals. M.p: 45 °C. Yield: 77 % (7.5 g). 1H-NMR ( C D C l 3 ) δ ppm: 1.40 (t, 3H, CH2-CH3), 2.33 (s, 3H, -CH3), 3.90 (s, 3H, N-CH3), 4.35 (q, 2H, CH2-CH3), (s, 1H, Pz-H). IR (KBr, v(cm−1)): 1690 (C=O).

3.2.2. Synthesis of 1,5-Dimethyl-1H-pyrazole-3-carboxylic Acid (A1)

Ethyl 1,5-dimethyl-1H-pyrazole-3-carboxylate (2 g, 11.89 mmol) and methanol (20 mL) were added to a NaOH (0.95 g, 23 mmol) aqueous solution (30 mL). The resulting mixture was stirred for 24 h. After cooling to 0°C, it was neutralized using dilute HCl, leading to a white precipitate. The precipitate was separated by filtration, washed with water (15 mL), and dried in a desiccator. M.p: 190 °C. Yield: 90% (1.8 g). 1H-NMR (DMSO-d6) δ ppm: 2.23 (s, 3H, C-C), 3.75 (s, 3H, C- N), 6.44 (s, 1H, C=CH-C). 13C-NMR (DMSO-d6) δ ppm: 11.2 (C-C-N), 37.1 (C-N-N), 108.3 (C=CH-C), 140.7 (C-C=C), 142.1 (CH-C-C=O), 163.9 (C-C-OH).

3.2.3. Synthesis of 1,5-Dimethyl-1H-pyrazol-3-carbonyl Chloride (A2)

A1 (2 g, 14.27 mmol) was dissolved in dichloromethane, CH2Cl2 (40 mL). Under stirring, thionyl chloride SOCl2 (2 mL) was added, and the mixture was heated to 90 °C for 24 h. Afterwards, the mixture was cooled. When CH2Cl2 and SOCl2 had completely evaporated, the resulting white solid was dissolved in dichloromethane and distilled water. The solution was then neutralized with sodium bicarbonate until reaching a pH = 5. The mixture was decanted using a separating funnel, and the organic phase was subsequently extracted with dichloromethane (20 mL). It was then dried using sodium sulfate and evaporated to dryness. A white solid was obtained. M.p: 80 °C. Yield: 70% (1.7 g). 1H-NMR ( C D C l 3 ) δ ppm: 2.16 (s, 3H, C-C), 3.84 (s, 3H, C-N), 6.59 (s, 1H, C=CH-C). 13C-NMR ( C D C l 3 ) δ ppm: 11.3 (C-C-N), 37.5 (C-N-N), 110.0 (C=CH-C), 141.5 (C-C=C), 142 (CH-C-C=O), 162 (C-C-Cl).

3.2.4. Synthesis of 1,5-Dimethyl-N-phenyl-1H-pyrazole-3-carboxamide (L1)

A solution of A2 (1 g, 6.30 mmol) (20 mL) was mixed with triethylamine (0.87 mL) and aniline (0.56 mL) in dichloromethane (10 mL), which was added slowly. The resulting mixture was heated at reflux for 24 h, followed by filtration, and was then cooled to room temperature and concentrated to dryness. The expected product was precipitated in petroleum ether and was purified by recrystallization in petroleum ether, resulting in a white powder. M.p: 150 °C. Yield: 93% (0.97 g). FT-IR: 3279(w), 2949(w), 2604(w), 2497(w), 1658 (s), 1537(s), 1035(s), 743(m), 576(w). 1H-NMR ( C D C l 3 ) δ ppm: 2.23 (s,3H, C-C), 3.74 (s, 3H, C-N), 6.55 (s, 1H, C=CH-C), 7.03 (t, 1H, CH=CH-CH), 7.27 (t, 1H, CH=CH-CH), 7.61 (d, 1H, C-CH=CH), 8.61 (s, 1H, NH-C). 13C-NMR ( C D C l 3 ) δ ppm: 11.3 (C-C-N), 36.6 (C-N-N), 106.4 (C=CH-C), 119.5 (C-CH=CH), 123.8 (CH-CH=CH), 128.9 (CH=CH-CH), 138.1 (NH-C-CH), 140.7 (C-C=CH), 145.1 (N=C-CH), 159.9 (O=C-NH). MS (ESI) (Methanol): m/z = 216 [M+H] + (calc. 215.2), (see Figures S1, S2 and S5).

3.2.5. Synthesis of 1,5-Dimethyl-N-propyl-1H-pyrazole-3-carboxamide (L2)

To a solution of A2 (0.60 g, 3.78 mmol) in dry toluene (10 mL) at 0 °C, a mixture of propylamine (0.65 mL, 3.73 mmol) and triethylamine (0.52 mL, 3.75 mmol) in toluene (20 mL) was slowly added. The resulting mixture was heated at reflux for 24 h. The reaction mixture was then filtered, and the solvent was removed under reduced pressure. The crude product was purified via column chromatography on silica gel (EtOAc/Hexane: 5/5), resulting in a white solid. M.p 72 °C. Yield 84% (0.51 g). FT-IR: 3276(w), 2948(w), 2603(w), 2495(w), 1685(s), 1241(m), 1037(s), 798(s), 577(w). 1H-NMR (DMSO) δ ppm: 0.83 (t, 3H, C-C), 1.47 (m, 2H, C-C-C), 2.25 (s, 3H, C-C), 3,14 (m, 2H, NH-C-C), 3.75 (s, 3H, C-N), 6.37 (s, 1H, C=CH-C), 7.92 (t, 1H, C-NH-C). 13C-NMR (DMSO) δ ppm: 11.3 (C-C-N), 11.9 (C-C), 23.1 (C-C-C), 36.8 (C-N-N), 40.6 (NH-C-C), 105.8 (C=CH-C), 140.6 (C-C=CH), 145.5 (N=C-C=O), 162.0 (O=C-NH). MS (ESI) (Methanol): m/z = 182 [M+H] + (calc.181.2), (see Figures S3, S4 and S6).

3.2.6. Synthesis of [Ni(L1)2](ClO4)2 (C1)

L1 (43.1 mg, 0.2 mmol, 2 equiv.) was dissolved in methanol (3 mL). Ni(ClO4)2·6H2O (36,6 mg, 0.1 mmol, 1 equiv.) was dissolved in methanol (3 mL) and added to the previous solution of L1. The mixture was stirred for 10 min at room temperature. After 4 days of slow evaporation, blue single crystals were obtained. Yield: 39% (29 mg). FT-IR: 3558(w), 3326(w), 3115(w), 1612 (s), 1566(s), 1058(s), 622(s), 508(m). HRMS (ESI) (CH3OH): m/z = 244.07280 [C24H26O2N658Ni], (see Figure S7).

3.2.7. Synthesis of [Cd2(L2)2]Cl4 (C2)

L2 (36.2 mg, 0.1 mmol, 3 equiv.) was dissolved in methanol (3 mL). CdCl2·H2O (24.2 mg, 0.1 mmol, 1 equiv.) was dissolved in methanol (3 mL), with the addition of five drops of water, and then added to the previous solution of L 2 . The mixture was stirred for 10 min at room temperature. The resulting clear liquid mixture was subjected to vapor diffusion with diethyl ether (10 mL) at room temperature. After 7 days, colorless crystals were obtained. Yield: 31% (21 mg). FT-IR: 3294(w), 3115(w), 2874(w), 1630(s), 1274(s), 1002(m), 625(s). HRMS (ESI) (CH3OH): m/z = 234.07423 [C18H30O2N6106Cd], (see Figure S8).

3.3. X-ray Crystallographic Studies

Diffraction data for L1, C1, and C2 were collected on an MAR345 Image plate detector using a monochromated (Montel optics) microfocus Mo-Kα radiation (λ = 0.71073 Å) source (Incoatec IµS). Data integration and reduction were performed using the CrysAlisPRO V 1.171.37.35 crystallographic software package and absorption correction was used [52].
The structures were solved by dual-space direct methods (SHELXT) [53] and refined by full matrix least squares on F2 using SHELXL [54]. All non-hydrogen atoms were refined anisotropically and hydrogen atoms were placed at the calculated positions with isotropic temperature factors fixed at 1.2 times the Ueq of the parent atoms (1.5Ueq for methyl and OH hydrogens).
In L1, methyl hydrogens showed rotational disorder and were refined as an idealized disordered methyl group with two positions rotated by 60°. In C1, the Ni complex showed whole-molecule disorder. The octahedral Ni complex consists of two L1 ligands in the equatorial plane with two methanol molecules in the axial positions, giving a perfectly symmetrical complex, with the Ni atom found at an inversion center. The disorder consists of a 90° rotation of the ligands within the same equatorial plane with a refined ratio of about 84/16. Additionally, the perchlorate anion is also disordered over two discrete positions in a 90/10 ratio. In C2, both dinuclear complexes in the asymmetric unit show disorder of the Cd cations, and, as a result, so do the coordinated Cl anion and methanol. The asymmetric unit could be seen as a mixture of the solvated dinuclear complex and the desolvated structure. As the overall geometrical differences between both structures are relatively small, both can be interchanged. As no deterioration of the diffraction was observed, it is less likely that the observed structure is an averaged structure where solvent evaporation occurred at the surface of the crystal during the measurement at ambient conditions, as this would result in non-stoichiometric ratios of both dinuclear complexes. Also, one of the propyl chains in both dinuclear complexes showed disorder that could be refined in two discrete positions in a 90/10 ratio.
Details of the crystallographic and refinement details for the compounds are listed in Table 4. CCDC 2290595-2290597 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/structures.

4. Biological Activity

4.1. Microorganisms and Culture Media

The bacterial strains utilized in this work were two Gram-positive (Staphylococcus aureus (S. aureus) and Listeria innocua (Li. innocua)) and two Gram-negative bacteria (Pseudomonas aeruginosa (Ps. aeruginosa) and Escherichia coli (E. coli)). These bacterial strains are involved in foodborne illnesses. The fungal strains tested in this work were Asperillus niger, Geotrichum candidum, and Penicillium crustosum. These fungi are involved in postharvest diseases of fruits and vegetables, and they can be associated with the production of mycotoxins, which are dangerous for human and animal health. All these microorganisms are available in the Laboratory of Bioresources, Biotechnology, Ethnopharmacology and Health, Univ. Mohammed Premier of Oujda. The culture media used for their culture were Mueller–Hinton medium (BIOKAR, Allonne, France) for bacteria and Potato Dextrose Agar (PDA) (BIOKAR, Allonne, France) for fungi.

4.2. Measurement of Antibacterial and Antifungal Activities

The solid-medium diffusion method (Mueller–Hinton medium) was used to determine antibacterial activity against bacteria (Listeria innocua, E. coli, Pseudomonas aeruginosa, and Staphylococcus aureus), and Potato Dextrose Agar medium (BIOKAR, France) for antifungal activity against Asperillus niger, Geotrichum candidum, and Penicillium crustosum. The strains were diluted and adjusted to 0.5 McFarland, which corresponds to 106 CFU/mL for bacteria and 106 spores/mL for molds. Cultures were diluted with Mueller–Hinton broth for bacteria, and with sterile physiological water for molds. An amount of 0.1 mL of each diluted strain was inoculated by surface spreading of the solid culture medium corresponding to each type of microorganism (bacteria or mold). An amount of 100 μL of each sample at a concentration of 6 mg/mL (DMSO) was filled into the wells made on the solid medium. The dishes were then incubated for 2 h at 4 °C and then at 37 °C for 24 h for bacteria and at 25 °C for fungi. The diameters of the inhibition zones obtained around the wells were measured. Cycloheximide and Gentamicin were used as positive controls against fungi and bacteria, respectively.

4.3. Antifungal Activity on Mycelial Growth of Fusarium oxysporum

Fusarium oxysporum isolates were obtained from xylem tissues showing typical “Bayoud” symptoms on Boufegousgharas date palm in Figuig, Morocco. Small vascular tissue fragments were removed and placed in sterile PDA medium, then incubated at 28 °C. The identification of Fusarium oxysporum isolates was carried out by observing their morphological features [55,56]. Following incubation on PDA medium at 28 °C, a single monoconidial Fusarium oxysporum was isolated.
A total of 4 mg of each molecule was dissolved in DMSO (1 mL). From this solution, 50 µL and 150 µL were placed in sterile tubes. Then, the sterile liquid PDA was added until reaching a total volume of 10 mL. The entire set was placed on Petri dishes with 8.5 cm diameter, and the medium was allowed to stand until solidification [51]. In the middle of each Petri dish was a pellet of FOA that had already grown on the solid PDA. The dishes were incubated for four days at 28 °C. By comparing the diameter of the FOA to a control that contained only DMSO at some dose (control), the results are reported as a percentage of inhibition as follows [52]:
%   o f   i n h i b i t i o n = D 0 − D x D 0 × 100
D0 = diameter (cm) of the FOA in the control.
Dx = diameter (cm) of the FOA in the test.

4.4. Genotoxicity Effect

To obtain blood samples, rats were anesthetized using pentobarbital, and samples were collected retro-orbitally using heparin-containing tubes. The collected blood (2 mL) from a male Wistar rat was mixed with an equal volume (2 mL) of CaII- and MgII-free phosphate-buffered saline (PBS) solutions (137 mM NaCl; 2.7 mM KCl; 10 mM Na2HPO4; 1.76 mM KH2PO4; pH 7.4). The diluted blood was then exposed to the samples. The samples were dissolved in PBS to achieve the desired concentrations (5 and 10 µg/mL). Subsequently, the diluted blood samples were incubated with the respective samples for two hours at 37 °C. The negative control was exposed to PBS, while hydrogen peroxide (250 µmol/L) was used as the positive control.
The comet assay, also known as the single-cell gel electrophoresis assay, is a commonly used technique to evaluate genotoxicity. It measures DNA damage in individual cells by visualizing the migration of fragmented DNA under an electric field. Several parameters are assessed in the comet assay, including tail moment, tail intensity, and tail length, which provide information about the extent and severity of DNA damage. Higher values of tail moment, tail intensity, and tail length indicate more significant genotoxic effects [57,58,59,60].
A modified version of the alkaline comet test protocol described in [61] was implemented with minor adjustments. Following treatment, the suspension was centrifuged at 4500 rpm for 10 min. The pellet containing leukocytes was then dissolved in PBS (1 mL) after removing the supernatant. The washing process was repeated three times. Subsequently, the pellet was dissolved in a solution of low-melting-point (LMP) agarose (0.5% w/v in PBS). The resulting mixture was applied to a slide previously coated with normal-melting-point (NMP) agarose (1.5% w/v). The slides were immersed in a lysis solution (2.5 M NaCl, 100 mM Na2EDTA, 20 mM Tris, 300 mM NaOH, 1% N-lauroylsarcosine sodium, 10% DMSO, and 1% Triton X-100) for 5 min, followed by 1 h of incubation in the dark at 4 °C. After the lysis period, the slides were thoroughly washed with double-distilled water. The slides were then placed in horizontal gel electrophoresis apparatus with an electrophoresis solution consisting of 300 mM NaOH and 1 mM Na2EDTA at pH 13. DNA unravelling was performed for 20 min at a constant current of 300 mA and a set voltage of 25 V. The temperature of the electrophoresis solution was maintained at 4 °C throughout the run. Following electrophoresis, the slides were immersed in a neutralization buffer (400 mM Trizma solution adjusted to pH 7.5 using HCl) for 5 min. This process was repeated three times. Finally, the comets were visualized using the ethidium bromide staining method [62].
The ethidium-bromide-stained slides were observed and captured using ZOE Cell Imager fluorescence microscopy, specifically utilizing the red channel with an excitation wavelength of 556/20 nm and an emission wavelength of 615/61 nm. To quantitatively estimate DNA damage, an image analyzer coupled with processing software was employed. In this study, Comet Assay IV image analysis software was utilized, enabling the quantification of various parameters associated with DNA lesions [63]. Two replicates were conducted for each sample, and a total of fifty cells were randomly selected for analysis in each replicate.

4.5. Statistical Analysis

Statistical analysis was performed using GraphPad Prism V9 software. A one-way ANOVA was utilized to assess the statistical significance of the data. Differences between treatment groups were examined using Tukey’s honest significance test, with significance thresholds set at p < 0.05, p < 0.01, p < 0.001, and p < 0.0001.

5. Conclusions

In this work, we have prepared two new molecules, 1,5-dimethyl-N-phenyl-1H-pyrazole-3-carboxamide (L1) and 1,5-dimethyl-N-propyl-1H-pyrazole-3-carboxamide (L2), based on pyrazoles and amides. Their reactivity with nickel and cadmium salts led to two complexes C1 and C2. We further support our study with biological investigations that showcased our coordination complexes as potential antibacterial and antifungal agents. We demonstrated that C2 has a remarkable antifungal activity compared to cycloheximide. This Cd coordination complex also exhibits a remarkable anti-Fusarium activity (96% inhibition) against Fusarium Oxysporum f. sp. Albedinis. We also investigated the genotoxicity of our ligands and coordination complexes using the comet assay, where we demonstrated that the addition of metal ions increased the genotoxicity, as expected, compared to our ligands. We believe that the development of less genotoxic coordination compounds with a high biological activity is an ideal future research direction.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules29051186/s1, Figures S1–S4: NMR spectroscopy of L1, L2, C1, C2. Figures S5–S8: mass spectroscopy of L1, L2, C1, C2.

Author Contributions

A.E.M. performed synthesis, characterization and wrote the paper with Y.G. and K.R.; S.R. and Y.G. both designed and managed the project; M.E.M. and Y.D. contributed to some organic syntheses; K.R. undertook X-ray studies; S.O., A.A., N.E.B., E.S. and R.B. performed biological experiments; All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the Fonds de la Recherche Scientifique—FNRS (PDR T.0095.21, CDR J.0064.23, J.0168.22, EQP U.N027.24), CNRST (PPR2-MESRSFC-CNRSTP10) and the COST action CA21149.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article and Supplementary Materials.

Acknowledgments

We thank WBI Morocco for granting a research stay for A.E.M. in Belgium. We thank the chemistry department at the University of Aveiro for providing mass spectral data and A. Talhaoui and staff members for open access to the analytical platform of the Faculty of Sciences of Oujda.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Cattoir, V.; Felden, B. Future Antibacterial Strategies: From Basic Concepts to Clinical Challenges. J. Infect. Dis. 2019, 220, 350–360. [Google Scholar] [CrossRef] [PubMed]
  2. World Health Organization. 2021 Antibacterial Agents in Clinical and Preclinical Development: An Overview and Analysis; World Health Organization: Geneva, Switzerland, 2021. [Google Scholar]
  3. Frei, A.; Zuegg, J.; Elliott, A.G.; Baker, M.; Braese, S.; Brown, C.; Chen, F.; Dowson, C.G.; Dujardin, G.; Jung, N.; et al. Metal Complexes as a Promising Source for New Antibiotics. Chem. Sci. 2020, 11, 2627–2639. [Google Scholar] [CrossRef] [PubMed]
  4. Swiatoslaw, T. Coordination Chemistry of Pyrazole-Derived Ligands. Chem. Rev. 1972, 72, 497–509. [Google Scholar] [CrossRef]
  5. Ebenezer, O.; Shapi, M.; Tuszynski, J.A. A Review of the Recent Development in the Synthesis and Biological Evaluations of Pyrazole Derivatives. Biomedicines 2022, 10, 1124. [Google Scholar] [CrossRef] [PubMed]
  6. Draoui, Y.; Radi, S.; Tanan, A.; Oulmidi, A.; Miras, H.N.; Benabbes, R.; Ouahhoudo, S.; Mamri, S.; Rotaru, A.; Garcia, Y. Novel Family of Bis-Pyrazole Coordination Complexes as Potent Antibacterial and Antifungal Agents. RSC Adv. 2022, 12, 17755–17764. [Google Scholar] [CrossRef]
  7. Oulmidi, A.; Rotaru, A.; Radi, S.; Garcia, Y. Pyrazole’s Substituents Effect on the Spin State of [Fe(Bpp)2]2+complexes. Hyperfine Interact. 2021, 242, 8. [Google Scholar] [CrossRef]
  8. Oulmidi, A.; Radi, S.; Miras, H.N.; Adarsh, N.N.; Garcia, Y. New Bis-Pyrazole-Bis-Acetate Based Coordination Complexes: Influence of Counter-Anions and Metal Ions on the Supramolecular Structures. Sustainability 2020, 13, 288. [Google Scholar] [CrossRef]
  9. Radi, S.; El-Massaoudi, M.; Benaissa, H.; Adarsh, N.N.; Ferbinteanu, M.; Devlin, E.; Sanakis, Y.; Garcia, Y. Crystal Engineering of a Series of Complexes and Coordination Polymers Based on Pyrazole-Carboxylic Acid Ligands. New J. Chem. 2017, 41, 8232–8241. [Google Scholar] [CrossRef]
  10. Chkirate, K.; Karrouchi, K.; Dege, N.; Kheira Sebbar, N.; Ejjoummany, A.; Radi, S.; Adarsh, N.N.; Talbaoui, A.; Ferbinteanu, M.; Essassi, E.M.; et al. Co(II) and Zn(II) Pyrazolyl-Benzimidazole Complexes with Remarkable Antibacterial Activity. New J. Chem. 2020, 44, 2210–2221. [Google Scholar] [CrossRef]
  11. Chkirate, K.; Karrouchi, K.; Chakchak, H.; Mague, J.T.; Radi, S.; Adarsh, N.N.; Li, W.; Talbaoui, A.; Essassi, E.M.; Garcia, Y. Coordination Complexes Constructed from Pyrazole–Acetamide and Pyrazole–Quinoxaline: Effect of Hydrogen Bonding on the Self-Assembly Process and Antibacterial Activity. RSC Adv. 2022, 12, 5324–5339. [Google Scholar] [CrossRef]
  12. Chkirate, K.; Fettach, S.; Karrouchi, K.; Sebbar, N.K.; Essassi, E.M.; Mague, J.T.; Radi, S.; El Abbes Faouzi, M.; Adarsh, N.N.; Garcia, Y. Novel Co(II) and Cu(II) Coordination Complexes Constructed from Pyrazole-Acetamide: Effect of Hydrogen Bonding on the Self Assembly Process and Antioxidant Activity. J. Inorg. Biochem. 2019, 191, 21–28. [Google Scholar] [CrossRef]
  13. Malek, F.; Ramdani, A.; Zidane, I.; Yahyi, A.; Radi, S. Tetrapyrazolic Tripods. Synthesis and Preliminary Use in Metal Ion Extraction. Tetrahedron 2005, 61, 2995–2998. [Google Scholar] [CrossRef]
  14. Malek, F.; Ramdani, A.; Radi, S. Pyrazolic Tripods Synthesis and Cation Binding Properties. J. Chem. Res. 2004, 2004, 640–641. [Google Scholar] [CrossRef]
  15. Radi, S.; Ramdani, A.; Lekchiri, Y.; Morcellet, M.; Crini, G.; Janus, L.; Martel, B. Extraction of Metal Ions from Water with Tetrapyrazolic Macrocycles Bound to Merrifield Resin and Silica Gel. J. Appl. Polym. Sci. 2000, 78, 2495–2499. [Google Scholar] [CrossRef]
  16. Mouadili, A.; Attayibat, A.; Kadiri, S.E.; Radi, S.; Touzani, R. Catecholase Activity Investigations Using in Situ Copper Complexes with Pyrazole and Pyridine Based Ligands. Appl. Catal. A Gen. 2013, 454, 93–99. [Google Scholar] [CrossRef]
  17. Radi, S.; Tighadouini, S.; Toubi, Y.; Bacquet, M. Polysiloxane Surface Modified with Bipyrazolic Tripodal Receptor for Quantitative Lead Adsorption. J. Hazard. Mater. 2011, 185, 494–501. [Google Scholar] [CrossRef] [PubMed]
  18. Radi, S.; Tighadouini, S.; Bacquet, M.; Degoutin, S.; Janus, L.; Mabkhot, Y.N. Fabrication and Covalent Modification of Highly Chelated Hybrid Material Based on Silica-Bipyridine Framework for Efficient Adsorption of Heavy Metals: Isotherms, Kinetics and Thermodynamics Studies. RSC Adv. 2016, 6, 82505–82514. [Google Scholar] [CrossRef]
  19. Radi, S.; El Abiad, C.; Carvalho, A.P.; Santos, S.M.; Faustino, M.A.F.; Neves, M.G.P.M.S.; Moura, N.M.M. An Efficient Hybrid Adsorbent Based on Silica-Supported Amino Penta-Carboxylic Acid for Water Purification. J. Mater. Chem. A 2018, 6, 13096–13109. [Google Scholar] [CrossRef]
  20. Radi, S.; Toubi, Y.; El-Massaoudi, M.; Bacquet, M.; Degoutin, S.; Mabkhot, Y.N. Efficient Extraction of Heavy Metals from Aqueous Solution by Novel Hybrid Material Based on Silica Particles Bearing New Schiff Base Receptor. J. Mol. Liq. 2016, 223, 112–118. [Google Scholar] [CrossRef]
  21. Radi, S.; Attayibat, A.; Ramdani, A.; Bacquet, M. Synthesis and Characterization of Novel Silica Gel Supported N-Pyrazole Ligand for Selective Elimination of Hg(II). Eur. Polym. J. 2008, 44, 3163–3168. [Google Scholar] [CrossRef]
  22. Cherrak, K.; Belghiti, M.E.; Berrissoul, A.; El Massaoudi, M.; El Faydy, M.; Taleb, M.; Radi, S.; Zarrouk, A.; Dafali, A. Pyrazole Carbohydrazide as Corrosion Inhibitor for Mild Steel in HCl Medium: Experimental and Theoretical Investigations. Surf. Interfaces 2020, 20, 100578. [Google Scholar] [CrossRef]
  23. Belghiti, M.; Tighadouini, S.; Karzazi, Y.; Dafali, A.; Hammouti, B.; Radi, S.; Solmaz, R. New Hydrazine Derivatives as Corrosion Inhibitors for Mild Steel Protection in Phosphoric Acid Medium. Part A: Experimental Study. J. Mater. Environ. Sci. 2016, 7, 337–346. [Google Scholar]
  24. Oulmidi, A.; Radi, S.; Idir, A.; Zyad, A.; Kabach, I.; Nhiri, M.; Robeyns, K.; Rotaru, A.; Garcia, Y. Synthesis and Cytotoxicity against Tumor Cells of Pincer N-Heterocyclic Ligands and Their Transition Metal Complexes. RSC Adv. 2021, 11, 34742–34753. [Google Scholar] [CrossRef]
  25. Ronco, C.; Martin, A.R.; Demange, L.; Benhida, R. ATM, ATR, CHK1, CHK2 and WEE1 Inhibitors in Cancer and Cancer Stem Cells. Med. Chem. Commun. 2017, 8, 295–319. [Google Scholar] [CrossRef]
  26. Radi, S.; Salhi, S.; Radi, A. Synthesis and Preliminary Biological Activity of Some New Pyrazole Derivatives as Acyclonucleoside Analogues. Lett. Drug Des. Discov. 2010, 7, 27–30. [Google Scholar] [CrossRef]
  27. Mabkhot, Y.; Al-Majid, A.; Barakat, A.; Al-Showiman, S.; Al-Har, M.; Radi, S.; Naseer, M.; Hadda, T. Synthesis and Biological Evaluation of 2-Aminobenzamide Derivatives as Antimicrobial Agents: Opening/Closing Pharmacophore Site. Int. J. Mol. Sci. 2014, 15, 5115–5127. [Google Scholar] [CrossRef]
  28. Karrouchi, K.; Fettach, S.; Anouar, E.H.; Tüzün, B.; Radi, S.; Alharthi, A.I.; Ghabbour, H.A.; Mabkhot, Y.N.; Faouzi, M.E.A.; Ansar, M.; et al. Synthesis, Crystal Structure, DFT, α-Glucosidase and α-Amylase Inhibition and Molecular Docking Studies of (E)-N’-(4-Chlorobenzylidene)-5-Phenyl-1H-Pyrazole-3-Carbohydrazide. J. Mol. Struct. 2021, 1245, 131067. [Google Scholar] [CrossRef]
  29. Cetin, A.; Kurt, H. Synthesis, Antibacterial Activity and Molecular Docking Studies of New Pyrazole Derivatives. Lett. Drug Des. Discov. 2020, 17, 745–756. [Google Scholar] [CrossRef]
  30. Karrouchi, K.; Radi, S.; Ramli, Y.; Taoufik, J.; Mabkhot, Y.; Al-aizari, F.; Ansar, M. Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review. Molecules 2018, 23, 134. [Google Scholar] [CrossRef] [PubMed]
  31. Rajput, A.; Mukherjee, R. Coordination Chemistry with Pyridine/Pyrazine Amide Ligands. Some Noteworthy Results. Coord. Chem. Rev. 2013, 257, 350–368. [Google Scholar] [CrossRef]
  32. Draoui, Y.; Radi, S.; El Massaoudi, M.; Bahjou, Y.; Ouahhoud, S.; Mamri, S.; Ferbinteanu, M.; Benabbes, R.; Wolff, M.; Robeyns, K.; et al. Coordination Complexes Built from a Ditopic Triazole-Pyrazole Ligand with Antibacterial and Antifungal Performances. Molecules 2023, 28, 6801. [Google Scholar] [CrossRef]
  33. Preti, C.; Tosi, G.; Filippo, D.D.; Verani, G. Cobalt(II) and Nickel(II) Complexes with Nitrogen, Sulfur, and Selenium Containing Heterocyclic Ligands. Can. J. Chem. 1974, 52, 2021–2028. [Google Scholar] [CrossRef]
  34. Popović, Z.V.; Stanišić, G.; Stojanović, D.; Kostić, R. Infrared and Raman Spectra of CdO. Phys. Status Solidi B 1991, 165, K109–K112. [Google Scholar] [CrossRef]
  35. Kamath, P.V.; Ganguly, S. Infrared Spectroscopic Studies of the Oxide-Hydroxides of Ni, Co and Mn. Mater. Lett. 1991, 10, 537–539. [Google Scholar] [CrossRef]
  36. Ali, I.; Wani, W.A.; Khan, A.; Haque, A.; Ahmad, A.; Saleem, K.; Manzoor, N. Synthesis and Synergistic Antifungal Activities of a Pyrazoline Based Ligand and Its Copper(II) and Nickel(II) Complexes with Conventional Antifungals. Microb. Pathog. 2012, 53, 66–73. [Google Scholar] [CrossRef] [PubMed]
  37. You, Z.; Zhu, H. Syntheses, Crystal Structures, and Antibacterial Activities of Four Schiff Base Copper(II), Zinc(II), and Cadmium(II) Complexes Derived from 2-[(2-Dimethylaminoethylimino)Methyl]Phenol. Z. Anorg. Allge Chem. 2006, 632, 140–146. [Google Scholar] [CrossRef]
  38. Bahjou, Y.; Radi, S.; El Massaoudi, M.; Draoui, Y.; Adarsh, N.N.; Miras, H.N.; Ferbinteanu, M.; Robeyns, K.; Ouahhoud, S.; Benabbes, R.; et al. High Inhibition for a Co II Tetrazole Bi-pyrazole Dinuclear Complex against Fusarium Oxysporum f. Sp. Albedinis. Eur. J. Inorg. Chem. 2023, e202300634. [Google Scholar] [CrossRef]
  39. Biswas, F.B.; Roy, T.G.; Rahman, M.A.; Emran, T.B. An in Vitro Antibacterial and Antifungal Effects of Cadmium(II) Complexes of Hexamethyltetraazacyclotetradecadiene and Isomers of Its Saturated Analogue. Asian Pac. J. Trop. Med. 2014, 7, S534–S539. [Google Scholar] [CrossRef] [PubMed]
  40. Dal Pizzol, M.; Freitas, E.C.; Locatelli, C.; Guareze, F.; Reginatto, P.; Machado, G.; Fuentefria, A.; Marinho, D. Antifungal Efficacy and Safety of Cycloheximide as a Supplement in Optisol-GS. Lett. Drug Des. Discov. 2021, 15, 2091–2098. [Google Scholar] [CrossRef] [PubMed]
  41. Mohamed, G.; Hassan, F.; Hossainy, A.; Khidr, M. Coordination Behaviour and Biological Activity Studies of Transition Metal Complexes with Indapamide and Mixed Ligands of Indapamide and Glycine. J. Pharm. 2012, 20125, 3753–3763. [Google Scholar]
  42. Montazerozohori, M.; Zahedi, S.; Nasr-Esfahani, M.; Naghiha, A. Some New Cadmium Complexes: Antibacterial/Antifungal Activity and Thermal Behavior. J. Ind. Eng. Chem. 2014, 20, 2463–2470. [Google Scholar] [CrossRef]
  43. Chandra, S.; Vandana; Kumar, S. Synthesis, Spectroscopic, Anticancer, Antibacterial and Antifungal Studies of Ni(II) and Cu(II) Complexes with Hydrazine Carboxamide, 2-[3-Methyl-2-Thienyl Methylene]. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2015, 135, 356–363. [Google Scholar] [CrossRef]
  44. Bahjou, Y.; Draoui, Y.; Radi, S.; Robeyns, K.; Li, W.; Miras, H.N.; Ferbinteanu, M.; Bentouhami, N.E.; Asehraou, A.; Rotaru, A.; et al. A Cu(II) Coordination Polymer as a Robust Inhibitor of Fusarium Oxysporum f. Sp. Albedinis; LCAE, Department of Chemistry, Faculty of Sciences, University Mohammed I: Oujda, Morocco, 2024; submitted. [Google Scholar]
  45. Islam, M.R.; Islam, S.M.R.; Noman, A.S.M.; Khanam, J.A.; Ali, S.M.M.; Alam, S.; Lee, M.-W. Biological Screening of a Novel Nickel (II) Tyrosine Complex. Mycobiology 2007, 35, 25–29. [Google Scholar] [CrossRef]
  46. Tighadouini, S.; Radi, S.; Abrigach, F.; Benabbes, R.; Eddike, D.; Tillard, M. Novel β-Keto–Enol Pyrazolic Compounds as Potent Antifungal Agents. Design, Synthesis, Crystal Structure, DFT, Homology Modeling, and Docking Studies. J. Chem. Inf. Model. 2019, 59, 1398–1409. [Google Scholar] [CrossRef] [PubMed]
  47. Kaddouri, Y.; Abrigach, F.; Ouahhoud, S.; Benabbes, R.; El Kodadi, M.; Alsalme, A.; Al-Zaqri, N.; Warad, I.; Touzani, R. Mono-Alkylated Ligands Based on Pyrazole and Triazole Derivatives Tested against Fusarium Oxysporum f. Sp. Albedinis: Synthesis, Characterization, DFT, and Phytase Binding Site Identification Using Blind Docking/Virtual Screening for Potent Fophy Inhibitors. Front. Chem. 2020, 8, 559262. [Google Scholar] [CrossRef] [PubMed]
  48. Benhusein, G.; Mutch, E.; Aburawi, S.; Williams, F. Genotoxic Effect Induced by Hydrogen Peroxide in Human Hepatoma Cells Using Comet Assay. Libyan J. Med. 2010, 5, 4637. [Google Scholar] [CrossRef]
  49. El-Habit, O.H.; Abdel Moneim, A.E. Testing the Genotoxicity, Cytotoxicity, and Oxidative Stress of Cadmium and Nickel and Their Additive Effect in Male Mice. Biol. Trace Elem. Res. 2014, 159, 364–372. [Google Scholar] [CrossRef]
  50. Permenter, M.G.; Lewis, J.A.; Jackson, D.A. Exposure to Nickel, Chromium, or Cadmium Causes Distinct Changes in the Gene Expression Patterns of a Rat Liver Derived Cell Line. PLoS ONE 2011, 6, e27730. [Google Scholar] [CrossRef]
  51. Cameron, K.S.; Buchner, V.; Tchounwou, P.B. Exploring the Molecular Mechanisms of Nickel-Induced Genotoxicity and Carcinogenicity: A Literature Review. Rev. Environ. Health 2011, 26, 81–92. [Google Scholar] [CrossRef]
  52. Agilent Technologies. CrysAlisPro, V 1.171. 37.35; Agilent Technologies: Santa Clara, CA, USA, 2014.
  53. Sheldrick, G.M. SHELXT—Integrated Space-Group and Crystal-Structure Determination. Acta Crystallogr. A Found. Adv. 2015, 71, 3–8. [Google Scholar] [CrossRef]
  54. Sheldrick, G.M. Crystal Structure Refinement with SHELXL. Acta Crystallogr. C Struct. Chem. 2015, 71, 3–8. [Google Scholar] [CrossRef]
  55. Nelson, P.E.; Toussoun, T.A.; Cook, R.J. (Eds.) Fusarium: Diseases, Biology, and Taxonomy; Pennsylvania State University Press: University Park, PA, USA, 1981; ISBN 978-0-271-00293-4. [Google Scholar]
  56. Booth, C. The Genus Fusarium; Commonwealth Agricultural Bureaux [for the] Commonwealth Mycological Institute: Farnham Royal, UK, 1971; ISBN 978-0-85198-046-1. [Google Scholar]
  57. Rossi, R.; Ciofalo, M. An Updated Review on the Synthesis and Antibacterial Activity of Molecular Hybrids and Conjugates Bearing Imidazole Moiety. Molecules 2020, 25, 5133. [Google Scholar] [CrossRef] [PubMed]
  58. Tice, R.R.; Agurell, E.; Anderson, D.; Burlinson, B.; Hartmann, A.; Kobayashi, H.; Miyamae, Y.; Rojas, E.; Ryu, J.-C.; Sasaki, Y.F. Single Cell Gel/Comet Assay: Guidelines for in Vitro and in Vivo Genetic Toxicology Testing. Environ. Mol. Mutagen. 2000, 35, 206–221. [Google Scholar] [CrossRef]
  59. Collins, A.R. The Comet Assay for DNA Damage and Repair: Principles, Applications, and Limitations. MB 2004, 26, 249–261. [Google Scholar] [CrossRef] [PubMed]
  60. Olive, P.L.; Banáth, J.P.; Durand, R.E. Heterogeneity in Radiation-Induced DNA Damage and Repair in Tumor and Normal Cells Measured Using the “Comet” Assay. Radiat. Res. 2012, 178, AV35–AV42. [Google Scholar] [CrossRef] [PubMed]
  61. Ouahhoud, S.; Khoulati, A.; Kadda, S.; Bencheikh, N.; Mamri, S.; Ziani, A.; Baddaoui, S.; Eddabbeh, F.-E.; Lahmass, I.; Benabbes, R.; et al. Antioxidant Activity, Metal Chelating Ability and DNA Protective Effect of the Hydroethanolic Extracts of Crocus Sativus Stigmas, Tepals and Leaves. Antioxidants 2022, 11, 932. [Google Scholar] [CrossRef]
  62. Singh, N.P.; McCoy, M.T.; Tice, R.R.; Schneider, E.L. A Simple Technique for Quantitation of Low Levels of DNA Damage in Individual Cells. Exp. Cell Res. 1988, 175, 184–191. [Google Scholar] [CrossRef]
  63. Strubbia, S.; Lyons, B.P.; Lee, R.J. Spatial and Temporal Variation of Three Biomarkers in Mytilus Edulis. Mar. Pollut. Bull. 2019, 138, 322–327. [Google Scholar] [CrossRef]
Molecules 29 01186 sch001
Scheme 1. Synthetic pathways leading to the formation of the ligands L1 and L2.
Scheme 1. Synthetic pathways leading to the formation of the ligands L1 and L2.
Molecules 29 01186 sch001
Molecules 29 01186 sch002
Scheme 2. Synthesis of the coordination complexes C1 and C2.
Scheme 2. Synthesis of the coordination complexes C1 and C2.
Molecules 29 01186 sch002
Molecules 29 01186 g001
Figure 1. FTIR spectroscopy comparison plot of L1, C1 (left panel) and L2, C2 (right panel).
Figure 1. FTIR spectroscopy comparison plot of L1, C1 (left panel) and L2, C2 (right panel).
Molecules 29 01186 g001
Molecules 29 01186 g002
Figure 2. View of the molecular structures of L1 (a), [Ni(L1)2](ClO4)2 (C1), (b) and [Cd2(L2)2]Cl4 (C2) (c). Disorder was omitted for clarity.
Figure 2. View of the molecular structures of L1 (a), [Ni(L1)2](ClO4)2 (C1), (b) and [Cd2(L2)2]Cl4 (C2) (c). Disorder was omitted for clarity.
Molecules 29 01186 g002
Molecules 29 01186 g003
Figure 3. Assessment of the impact of L1, L2 and C1, C2 on (A) DNA tail length, (B) the percentage of tail intensity, and (C) DNA tail moment in rat leukocytes. Results presented as means ± SEM (50 cells × 2). # p < 0.05 compared with negative control; * p < 0.05 compared with H2O2.
Figure 3. Assessment of the impact of L1, L2 and C1, C2 on (A) DNA tail length, (B) the percentage of tail intensity, and (C) DNA tail moment in rat leukocytes. Results presented as means ± SEM (50 cells × 2). # p < 0.05 compared with negative control; * p < 0.05 compared with H2O2.
Molecules 29 01186 g003
Table 1. Inhibition zones (mm) of bacterial targets obtained with L1, L2, C1, C2, and other reference compounds.
Table 1. Inhibition zones (mm) of bacterial targets obtained with L1, L2, C1, C2, and other reference compounds.
CompoundC
(mmol/L)		Inhibition Zone (mm)Ref.
E. coli [n]Li. Innocua [p]Ps. Aeruginosa [n]S. Aureus [p]
L127.89.20 ± 0.53 * 7.94 ± 0.40 *9.17 ± 1.04 *8.17 ± 0.76 *This work
C17.989.65 ± 0.28 *10.20 ± 0.28 *10.15 ± 0.28 *10.6 ± 0.28 *This work
L233.19.30 ± 0.17 *8.33 ± 1.15 *9.17 ± 0.85 *7.10 ± 1.56 *This work
C27.8816.10 ± 0.28 *14 ± 0.28 *14.7 ± 0.57 *12.8 ± 0.28 *This work
Gentamicin1.2529.9 ± 0.2830.10 ± 0.2827.75 ± 0.3532.85 ± 0.70This work
[Cd2(dmamp)2 (NCS)2]n---9.2--13.1--[37]
[Ni(btbepa)CH3OH(H2O)](ClO4)2--28----27[6]
H3O[Ni(dmptr)3](ClO4)34.6212 ± 0.38----12 ± 0.25[32]
[Cd(dmptr)2 Cl2]7.8527 ± 0.25----27 ± 0.19[32]
[Cd(htcd)(SCN)]SCN--22----24[39]
[NiL3](ClO4)23.498 ± 0.89 ± 0.359 ± 0.958 ± 0.35[38]
CdL2Cl25.2514 ± 0.7511 ± 0.512 ± 0.311 ± 0.5[38]
Ni(ClO4)2·6H2O8.20000[38]
CdCl2·H2O14.911 ± 0.308 ± 0.20[38]
[p]: Gram positive; [n]: Gram negative. * p < 0.05 compared with Gentamicin. dmamp = 2-[(2-dimethylaminoethylimino)methyl]phenol). btbepa = N,N-bis(2-(10,5,50-trimethyl-1H,10H-[3,30-bipyrazol]-1-yl)ethyl)propan-1-amine. dmptr = 3-(3,5-dimethyl-1H-pyrazol-1-yl)-1H-1,2,4-triazole. htcd = 5,7,7,12,14,14-hexamethyl-1,4,8,11-tetraazacyclotetradeca-4,11-diene. L = 2-(3,5,5′-trimethyl-1′H-[1,3′-bipyrazol]-1′-yl)acetonitrile.
Table 2. Inhibition zones (mm) of fungal targets obtained with L1, L2, C1, and C2 and comparison with the literature.
Table 2. Inhibition zones (mm) of fungal targets obtained with L1, L2, C1, and C2 and comparison with the literature.
CompoundC
(mmol/L)		Inhibition Zone (mm)Ref.
G.candidumA. nigerP. crustosum
L127.8713.9 ± 0.1 *10.25 ± 0.75 *8.8 ± 0.2 *This work
C17.9815.5 ± 0.71 *19 ± 1.41 *22 ± 1.41This work
L233.1112.5 ± 0.6 *9.85 ± 0.65 *8.25 ± 0.25 *This work
C27.8820 ± 1.41 *24.5 ± 0.71 *26 ± 2.83 *This work
Cycloheximide21.3322.8 ± 0.222.7 ± 0.522.6 ± 0.6This work
Cycloheximide (lower concentration)10.6622 ± 0.822 ± 0.722 ± 0.6This work
[Ni(IND)2(Gly)(H2O) 2]Cl--22.7 ± 0.03----[41]
Cd(bdade)(NCS)2----18.44--[42]
[Ni(psi)2SO4]----10--[43]
[Ni(CH3COO)2(Tyr)2] Tyr = Tyrosine----23--[45]
[NiL3](ClO4)23.49099 ± 0.1[38]
CdL2Cl25.2514 ± 0.214 ± 0.815 ± 0.45[38]
Ni(ClO4)2·6H2O8.2000[38]
CdCl2·H2O14.910 ± 0.16 ± 0.35 ± 0.2[38]
* p < 0.05 compared with cycloheximide (T+). IND = indapamide; Gly = glycine; bdade = bis(3(4-dimethylaminophenyl)-allylidene)-1,2-diaminoethane; psi = hydrazine carboxamide, 2-[3-methyl-2-thienylmethylene]; L = 2-(3,5,5′-trimethyl-1′H-[1,3′-bipyrazol]-1′-yl) acetonitrile.
Table 3. Antifusariam activities of L1, L2, C1, C2, and reference compounds for different sample volumes.
Table 3. Antifusariam activities of L1, L2, C1, C2, and reference compounds for different sample volumes.
CompoundSample Volumes (µL)C (µmol/L)Inhibition (%)Ref.
L15092.946.3 ± 2.5 *This work
150278.750 ± 4.5
C15026.643.8 ± 3.3This work
15079.862.5 ± 2.2 *
L250110.3550 ± 7.8 *This work
150331.0557.5 ± 6.6
C25026.387.5 ± 3.3 *This work
15078.996.3 ± 1.3 *
Cycloheximide5071.135 ± 3.3This work
150213.355 ± 2.5
250355.566.7 ± 2.9
Cd(dmptr)2 Cl2200104.650[32]
(H3O)[Ni(dmptr)3](ClO4)320029.4138[32]
[Ni(btbepa)CH3OH(H2O)](ClO4)220068.844[6]
NiL3(ClO4)215066.4235[38]
CdL2Cl215097.7551[38]
Co2(HL2)L2Cl315081.197[38]
Cu2(HL’2)Cl2150158.0297[44]
Ni(ClO4)2·6H2O150164.078[38]
CdCl2·H2O150298.0112[38]
* p < 0.05 compared to cycloheximide (T+), btbepa = N,N-bis(2-(10,5,50-trimethyl-1H,10 H-[3,30-bipyrazol]-1-yl)ethyl) propan-1-amine; dmptr = 3-(3,5-dimethyl-1H-pyrazol-1-yl)-1H-1,2,4-triazole; L = 2-(3,5,5′-trimethyl-1′H-[1,3′-bipyrazol]-1′-yl)acetonitrile; HL2 = 1′-((1H-tetrazole-5-yl)methyl)-3,5,5′-trimethyl-1′H-1,3′-bipyrazole; HL2′ = 5-((3-(3,5-dimethyl-1H-pyrazol-1-yl)-1H-1,2,4-triazol-1-yl)methyl)-406 1H-tetrazole.
Table 4. Crystal data and structure refinement for L1, C1, and C2.
Table 4. Crystal data and structure refinement for L1, C1, and C2.
CompoundL1C1C2
Empirical formulaC12 H13 N3 OC26 H34 Cl2 N6 Ni O12C38 H68 Cd4 Cl8 N12 O6
Formula weight215.25752.201522.24
T (K)293(2)293(2)293(2)
Wavelength (Å)0.710730.710730.71073
Crystal systemOrthorhombicMonoclinicOrthorhombic
Space groupPbcaP21/nPca21
Unit cell dimensions (Å,°)a = 10.4982(4)a = 10.6244(6)a = 16.7846(3)
b = 9.8653(4)b = 13.0110(7)b = 16.4470(3)
c = 21.4838(9)c = 11.8231(7)c = 20.9709(3)
α = 90α = 90α = 90
β = 90β = 96.503(6)β = 90
γ = 90γ = 90γ = 90
V (Å3)2225.04(15)1623.84(16)5789.16(16)
Z824
Density (calculated) (g/cm3)1.2851.5381.747
Absorption coefficient (mm−1)0.0850.8321.869
F(000)9127803024
Crystal size (mm3)0.32 × 0.15 × 0.120.35 × 0.30 × 0.200.40 × 0.25 × 0.20
θrange for data collection (°)2.988 to 26.1932.902 to 26.2322.893 to 26.187
Reflections collected164101104039165
Independent reflections2215 [R(int) = 0.0480]3199 [R(int) = 0.0253]11,407 [R(int) = 0.0185]
Completeness to θ 25.242° (%)99.298.998.9
Max. and min. transmission1.00000 and 0.825691.00000 and 0.882731.00000 and 0.66350
Data/restraints/parameters2215/0/1473199/99/27311407/43/721
Goodness-of-fit on F21.0861.0451.070
Final R indices [I > 2s(I)] R1 = 0.0441, wR2 = 0.1216R1 = 0.0374, wR2 = 0.1059R1 = 0.0188, wR2 = 0.0486
R indices (all data) R1 = 0.0488, wR2 = 0.1254R1 = 0.0398, wR2 = 0.1079R1 = 0.0197, wR2 = 0.0490
Absolute structure parameter ..0.31(2)
Δρ(max, min)(e.Å−3) 0.187, −0.1700.411, −0.2890.528, −0.371
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

El Mahdaoui, A.; Radi, S.; Draoui, Y.; El Massaoudi, M.; Ouahhoud, S.; Asehraou, A.; Bentouhami, N.E.; Saalaoui, E.; Benabbes, R.; Robeyns, K.; et al. Synthesis, Crystal Structures, Genotoxicity, and Antifungal and Antibacterial Studies of Ni(II) and Cd(II) Pyrazole Amide Coordination Complexes. Molecules 2024, 29, 1186. https://doi.org/10.3390/molecules29051186

AMA Style

El Mahdaoui A, Radi S, Draoui Y, El Massaoudi M, Ouahhoud S, Asehraou A, Bentouhami NE, Saalaoui E, Benabbes R, Robeyns K, et al. Synthesis, Crystal Structures, Genotoxicity, and Antifungal and Antibacterial Studies of Ni(II) and Cd(II) Pyrazole Amide Coordination Complexes. Molecules. 2024; 29(5):1186. https://doi.org/10.3390/molecules29051186

Chicago/Turabian Style

El Mahdaoui, Amal, Smaail Radi, Youssef Draoui, Mohamed El Massaoudi, Sabir Ouahhoud, Abdeslam Asehraou, Nour Eddine Bentouhami, Ennouamane Saalaoui, Redouane Benabbes, Koen Robeyns, and et al. 2024. "Synthesis, Crystal Structures, Genotoxicity, and Antifungal and Antibacterial Studies of Ni(II) and Cd(II) Pyrazole Amide Coordination Complexes" Molecules 29, no. 5: 1186. https://doi.org/10.3390/molecules29051186

APA Style

El Mahdaoui, A., Radi, S., Draoui, Y., El Massaoudi, M., Ouahhoud, S., Asehraou, A., Bentouhami, N. E., Saalaoui, E., Benabbes, R., Robeyns, K., & Garcia, Y. (2024). Synthesis, Crystal Structures, Genotoxicity, and Antifungal and Antibacterial Studies of Ni(II) and Cd(II) Pyrazole Amide Coordination Complexes. Molecules, 29(5), 1186. https://doi.org/10.3390/molecules29051186

Article Metrics

Back to TopTop